Report
Asia Pacific Major Report - A New Era Of Life Sciences Growth
Asia Pacific is home to approximately 60% of the global population. The region includes the many of the world’s most populous and fastest-growing countries as well as several
June 17, 2021
Looking for a PDF of this content?
- Asia Pacific is home to approximately 60% of the global population. The region includes the many of the world’s most populous and fastest-growing countries as well as several rapidly ageing societies.
- Supported by expanding demand from a large and ageing population and a steady flow of M&A activity, recent years have seen the life sciences industry experience rapid growth in Asia Pacific.
- Although global pharmaceutical giants from the U.S. and Europe continue to dominate the market, homegrown firms are expanding rapidly. Other key developments include the emergence of Asia Pacific life science clusters with the talent, infrastructure, facilities, manufacturing capacity and other critical environments required to meet the industry’s highly specialised demands.
- This report by CBRE Research provides an overview of Asia Pacific life sciences real estate, focusing on the key trends, demand drivers, corporate real estate strategies and investment opportunities in the region’s major life sciences hubs.
Key Trends & Industry News
Top 10 Asia Pacific Locations for Life Sciences Companies
Research Contacts
Henry Chin, Ph.D.
Global Chief Operating Officer, Research and Global Head of Investor Thought Leadership
Advisory & Transaction Services Contacts
Manish Kashyap
Global President, Advisory & Transaction Services
Rohini Saluja
Managing Director, Head of Consulting and Integrated Client Solutions, Asia Pacific
Paul Hubbard-Brown
Executive Director, Advisory & Transaction Services, Asia Pacific
Evvanna Chua
Head of Transaction Management, Southeast Asia
Capital Markets Contacts
Greg Hyland
Head of Capital Markets, Asia Pacific, CBRE
